Logo

Qiagen s Acquisition of Eppendorf Tops Most-Read GenomeWeb Daily News Stories Last Week

Jan 09, 2006

NEW YORK, Jan. 9 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Jan. 6.

 

1. Qiagen Acquires Eppendorf's Reagent Business; Firms to Align Techs (from Jan. 5)

2. As 454 Enabled Mammoth Project, Next-Generation Sequencers Will Drive Paleogenomics (from Jan. 3)

3. Predictive Diagnostics Closes Doors as Nasdaq Delists LSBC (from Jan. 3)

4. Third Wave CEO Gets New Salary; FDA Names Acting Tox Director; Exiqon Announces Head of US Operations; and Others (from Jan. 4)

5. Without Roche, Epigenomics Completes Validation Study for Prostate Cancer Dx (from Jan. 4)

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.